THIS COURSE WILL PRESENT THE PROCEDURES THAT MUST 2013 - 2-day In-person Seminar on Statistical Process Control for Process Development and Validation Philadelphia
View: 310
Website http://bit.ly/UwWWvO |
Edit Freely
Category Medical Device, Pharma, Biotech, Clinical, Drug, Food Safety, Heath,FDA
Deadline: May 23, 2013 | Date: May 24, 2013-May 25, 2013
Venue/Country: California, U.S.A
Updated: 2013-04-02 16:24:13 (GMT+9)
Call For Papers - CFP
Overview:This course will present the procedures that must be used in the application of DOE and SPC to the development, design and monitoring of manufacturing and testing processes. A practical approach with case studies and examples will be used, with theoretical information introduced only when necessary to understand an experiment. Examples from real processes and testing procedures will be used to present the student with examples that will be directly applicable to their work. Why you should attend:Any pharmaceutical worker who performs, supervises or reviews manufacturing or testing processes needs to understand the relationships among the process parameters and be able to monitor the performance of processes and test methods. This is particularly true for the worker in Quality Control and Quality Assurance as the recent FDA guidance document on Process Validation has assigned the responsibility for reviewing and interpreting DOE and SPC studies to the Quality Unit. The work, however, is done by the development, manufacturing, or quality systems worker who should also attend this course to learn how to design the systems and studies, and interpret the results generated.Course Outline:Day 1 ? AgendaDietary Design of ExperimentsLecture 1: IntroductionLecture 2: One Level, One Factor Designs. Simple Comparisons. Lecture 3: Two-Level Multi-factorial DesignLecture 4: Extracting Information from the ExperimentDay 2 ? AgendaStatistical Process ControlLecture 5: Shewhart Charts for Variable DataLecture 6: Shewhart Charts for Attribute Data Especially Counts.Lecture 7: Considerations from Shewhart ChartsLecture 8: Other Types of Charts Related to Shewhart Charts Who Will Benefit:? Directors? Managers? Supervisors? Lead workers in Process Development? Manufacturing? Regulatory Affairs? Quality Assurance and Quality Control? Workers who will be participating in operations or the supervision of the development, manufacturing, or testing of medicinal products will benefit from knowing the procedures and applications of DOE and SPC.About Speaker: Dr. Steven S. Kuwahara Ph.D. is the founder and Principal of GXP Biotechnology LLC, a consulting firm that works in the areas covered by the GLP and GMP of drugs, biologics, and nutraceuticals. Steve has over 30 years of experience in supervising quality control laboratories, including an animal testing facility, and in performing GLP and GMP audits of internal and external testing laboratories. Steve has participated in the development of drugs and biological through all phases of clinical research and final product production.DATE, VENUE & PRICE:Location: Philadelphia, PA | May 23rd & 24th, 2013 (Thursday & Friday) | 9 AM to 6 PM EDT Venue: Double Tree by Hilton Hotel Philadelphia Center CityPrice: $1,295.00Register now and save $200. (Early Bird)Until March 29, Early Bird Price: $1,295.00 From March 30 to May 21, Regular Price: $1,495.00Contact Information: Event CoordinatorToll free: 1800 447 9407Fax: 302 288 6884Email: support
globalcompliancepanel.comWebsite: https://www.globalcompliancepanel.com
LIVE CHAT SUPPORT ALSO - http://www.globalcompliancepanel.com/chat/client.php
GlobalCompliancePanelNetZealous LLC43337 Livermore Common, Fremont CA 94539, USA http://bit.ly/TpzYAN
Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.